Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
48
BRKR Quote, Financials, Valuation and Earnings
Last price:
$58.25
Seasonality move
:
5.37%
Day range:
$57.51 - $58.91
52-week range:
$48.07 - $94.86
Dividend yield:
0.34%
P/E ratio:
28.00x
P/S ratio:
2.66x
P/B ratio:
4.89x
Volume:
463K
Avg. volume:
1.6M
1-year change:
-20.98%
Market cap:
$8.8B
Revenue:
$3B
EPS (TTM):
$2.08
Analysts' Opinion
-
Consensus RatingBruker has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $74.01, Bruker has an estimated upside of 27.05% from its current price of $58.25.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $60.00 representing 100% downside risk from its current price of $58.25.
Fair Value
-
According to the consensus of 12 analysts, Bruker has 27.05% upside to fair value with a price target of $74.01 per share.
BRKR vs. S&P 500
-
Over the past 5 trading days, Bruker has underperformed the S&P 500 by -2.12% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Bruker does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Bruker has grown year-over-year revenues for 16 quarters straight. In the most recent quarter Bruker reported revenues of $864.4M.
Earnings Growth
-
Bruker earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Bruker reported earnings per share of $0.27.
Enterprise value:
11B
EV / Invested capital:
2.66x
Price / LTM sales:
2.66x
EV / EBIT:
25.71x
EV / Revenue:
3.40x
PEG ratio (5yr expected):
2.33x
EV / Free cash flow:
70.30x
Price / Operating cash flow:
55.03x
Enterprise value / EBITDA:
18.46x
Gross Profit (TTM):
$1.6B
Return On Assets:
6.2%
Net Income Margin (TTM):
9.41%
Return On Equity:
19.61%
Return On Invested Capital:
9.46%
Operating Margin:
9.07%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $2.5B | $2.8B | $3.2B | $742.8M | $864.4M | |
| Gross Profit | $1.3B | $1.4B | $1.6B | $382.8M | $418.8M | |
| Operating Income | $445.3M | $481.1M | $351.3M | $129.8M | $78.4M | |
| EBITDA | $504.7M | $542.6M | $596.6M | $149.7M | $117.9M | |
| Diluted EPS | $1.83 | $2.17 | $2.08 | $0.60 | $0.27 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.8B | $2B | $2B | $2B | $2.2B | |
| Total Assets | $2.9B | $3.1B | $3.3B | $3.8B | $6.1B | |
| Current Liabilities | $683.2M | $921.2M | $864.6M | $1.1B | $1.3B | |
| Total Liabilities | $1.9B | $2B | $2.4B | $2.6B | $4.3B | |
| Total Equity | $962.7M | $1.1B | $953.7M | $1.2B | $1.8B | |
| Total Debt | $829.9M | $827M | $1.2B | $1.2B | $2.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $241.5M | $316.1M | $266.8M | $44.1M | $38.4M | |
| Cash From Investing | -$150.9M | -$438.5M | -$1.7B | -$155M | -$67.6M | |
| Cash From Financing | $25.1M | -$169.6M | $1.2B | -$92.5M | -$2.7M | |
| Free Cash Flow | $118.5M | $206.1M | $156.7M | $17.2M | $5.8M | |
BRKR
Sector
Market Cap
$8.8B
$46.1M
Price % of 52-Week High
61.41%
46.02%
Dividend Yield
0.34%
0%
Shareholder Yield
-5.18%
-0.6%
1-Year Price Total Return
-20.99%
-30.52%
Beta (5-Year)
1.177
0.772
Dividend yield:
0.34%
Annualized payout:
$0.20
Payout ratio:
9.81%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$57.01
200-day SMA
Sell
Level
$68.32
Bollinger Bands (100)
Sell
Level
57.08 - 65.96
Chaikin Money Flow
Buy
Level
75.3M
20-day SMA
Buy
Level
$58.12
Relative Strength Index (RSI14)
Buy
Level
51.69
ADX Line
Buy
Level
16.59
Williams %R
Neutral
Level
-50.2058
50-day SMA
Buy
Level
$57.94
MACD (12, 26)
Sell
Level
-0.23
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Neutral
Level
65.1M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.4262)
Sell
CA Score
(Annual)
Level (-0.3671)
Buy
Beneish M-Score
(Annual)
Level (-2.231)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-0.0298)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
Stock Forecast FAQ
In the current month, BRKR has received 7 Buy ratings 5 Hold ratings, and 0 Sell ratings. The BRKR average analyst price target in the past 3 months is $74.01.
-
Where Will Bruker Stock Be In 1 Year?
According to analysts, the consensus estimate is that Bruker share price will rise to $74.01 per share over the next 12 months.
-
What Do Analysts Say About Bruker?
Analysts are divided on their view about Bruker share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bruker is a Sell and believe this share price will drop from its current level to $60.00.
-
What Is Bruker's Price Target?
The price target for Bruker over the next 1-year time period is forecast to be $74.01 according to 12 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is BRKR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Bruker is a Buy. 7 of 12 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of BRKR?
You can purchase shares of Bruker via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bruker shares.
-
What Is The Bruker Share Price Today?
Bruker was last trading at $58.25 per share. This represents the most recent stock quote for Bruker. Yesterday, Bruker closed at $58.25 per share.
-
How To Buy Bruker Stock Online?
In order to purchase Bruker stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
